Dhingra, S., & Sachdeva, M. (2017). Expanding horizons in the treatment of mantle cell lymphoma: Ibrutinib a novel BTK-targeting inhibitor. International Journal of Basic & Clinical Pharmacology, 3(1), 249–254. Retrieved from https://www.ijbcp.com/index.php/ijbcp/article/view/991